PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportschronic hepatitis c
MeSH D019698 - chronic hepatitis c
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D006526:Hepatitis c
7 Companies
16 Drugs
$
Success rate
D006521:Chronic hepatitis
0 Companies
0 Drugs
Success rate
D019698: 
Chronic hepatitis c
20 Companies
22 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaRibavirin Ribavirin  2004-10-04   
Ribavirin Ribavirin Teva  2009-03-31   
Ribavirin Ribavirin Teva Pharma B.V  2009-07-01   
Sofosbuvir Sofosbuvir  2022-01-27   
MylanRibavirin Ribavirin Mylan (previously Ribavirin Three Rivers)  2010-06-10   
Johnson & JohnsonTelaprevir Incivo  2011-09-19   
Simeprevir Olysio 2025-05-19 2013-11-22   
RocheRibavirin Copegus  2002-12-03   
Ribavirin, Peginterferon alfa-2a Pegasys Copegus  2004-06-04   
Interferon alfa-2a Roferon-A  1986-06-04   
SandozRibavirin Ribavirin  2006-10-03   
AbbVieDasabuvir Exviera  2015-01-14   
Glecaprevir, Pibrentasvir Maviret  2017-07-26   
Ritonavir, Ombitasvir, Paritaprevir Technivie 2024-08-25 2015-07-24   
Ritonavir, Dasabuvir, Ombitasvir, Paritaprevir Viekira 2024-08-25 2014-12-19 $16 M Q2/19-Q1/20 
Ritonavir, Ombitasvir, Paritaprevir Viekirax  2015-01-14   
Bausch Health CompaniesRibavirin Virazole  1985-12-31   
Merck & CoRibavirin Cotronak  1999-05-07   
Interferon alfa-2b Intron A  1986-06-04   
Interferon alfa-2b IntronA  2000-03-09   
Peginterferon alfa-2b PegIntron  2001-01-19   
Ribavirin, Peginterferon alfa-2b PegIntron/ Rebetol Combo Pack  2008-06-13   
Ribavirin Rebetol  1998-06-03   
Boceprevir Victrelis 2024-12-22 2011-05-13   
Interferon alfa-2b Viraferon  2000-03-09   
Peginterferon alfa-2b ViraferonPeg  2000-05-28   
Elbasvir, Grazoprevir Zepatier 2029-07-24 2016-01-28 $167 M Y2020 
Aurobindo PharmaRibavirin Ribavirin  2009-09-17   
Zydus TherapeuticsRibavirin Ribavirin  2005-12-05   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
73%
32/44
Phase 2
69%
41/59
Phase 3
74%
68/92
Approved: 38Overall Success rate: 37%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Ribavirin,
PIDILIZUMAB
Johnson & Johnson
Telaprevir,
Simeprevir,
Adafosbuvir,
Odalasvir,
SAMATASVIR,
Mk0518,
TMC647055,
IDX719
Roche
Ribavirin,
Peginterferon alfa-2a,
Interferon alfa-2a,
Interferon beta,
Danoprevir,
Escitalopram,
Alanine,
Alfacalcidol,
Pegargiminase,
Albinterferon alfa-2b,
BALAPIRAVIR,
MERICITABINE,
MIRAVIRSEN,
Patupilone,
SETROBUVIR,
Insulin,
Retinol,
Fendrix,
Viaject,
Cam2038,
Lactams,
Lexapro,
RO5428029,
Subutex
Sandoz
Ribavirin
AbbVie
Ritonavir,
Dasabuvir,
Glecaprevir,
Ombitasvir,
Paritaprevir,
Pibrentasvir,
Tozadenant,
Alfacalcidol,
Nadide,
Cam2038,
Mk0518,
Vekirax,
Arm1,
Arm2,
Subutex
Bausch Health Companies
Ribavirin,
Pegargiminase,
Interferon alfacon-1,
Albinterferon alfa-2b,
Taribavirin,
Viramidine
Merck & Co
Ribavirin,
Interferon alfa-2b,
Peginterferon alfa-2b,
Elbasvir,
Grazoprevir,
Boceprevir,
Benzocaine,
Benzylpenicillin,
Antithrombin iii,
Vitamin e,
Narlaprevir,
Vaniprevir,
Alanine,
Edrecolomab,
Adefovir,
Pegargiminase,
Albinterferon alfa-2b,
Bevifimod,
BIMIRALISIB,
Nadide,
Ruzasvir,
SAMATASVIR,
UPRIFOSBUVIR,
Valine,
VALOPICITABINE,
Insulin,
Sodium polystyrene sulfonate,
Fendrix,
Viaject,
Cam2038,
TMC647055,
Idx21459,
Antacid,
Arm1,
Hepsera,
Arm2,
IDX184,
Cocoa,
IDX719,
Subutex
Aurobindo Pharma
Ribavirin
Zydus Therapeutics
Ribavirin
Bristol Myers Squibb
Daclatasvir,
Asunaprevir,
Beclabuvir,
Alfacalcidol,
Arm1,
Trinessa,
Arm2
Astellas Pharma
Fk788
Gilead Sciences
Sofosbuvir,
Velpatasvir,
Ledipasvir,
Voxilaprevir,
Danoprevir,
Asunaprevir,
Tenofovir,
Pegargiminase,
Bevifimod,
NIVOCASAN,
RADALBUVIR,
TEGOBUVIR,
VEDROPREVIR,
VESATOLIMOD,
Fendrix,
Cam2038,
Arm1,
Arm2,
Subutex
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use